Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Uterine Fibroids Clinical Trials
Uterine Fibroids clinical trials are recruiting across 29 cities. Here are the cities with the most active studies:
Uterine Fibroids Trial Phases
9 research organizations are sponsoring uterine fibroids trials.
About Uterine Fibroids
Uterine fibroids are non-cancerous growths of the uterus that often appear during childbearing years. They can cause heavy bleeding, pelvic pain, and reproductive issues. Treatment options include medications, focused ultrasound, uterine artery embolization, and surgery.
Clinical trials are advancing new treatments for uterine fibroids. Currently, 9 studies are recruiting a combined 2,302 participants across the United States. Research is being conducted by 9 organizations including Sumitomo Pharma Switzerland GmbH, University of Cincinnati, InSightec and 6 others.
2026 Uterine Fibroids Research Landscape
As of July 2026, the uterine fibroids clinical trial landscape includes 9 actively recruiting studies across 29 cities in the United States. These studies are collectively seeking 2,302 participants, with an average enrollment target of 256 per study.
The research spans multiple phases of development: 2 studies are in NA, 2 studies are in PHASE1, 2 studies are in PHASE2, 1 study is in PHASE3, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some uterine fibroids treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 9 different organizations, including Sumitomo Pharma Switzerland GmbH, University of Cincinnati, InSightec, University of California, San Francisco, The University of Texas Health Science Center, Houston, and 4 others.
Geographically, uterine fibroids trials are most concentrated in Rochester, Minnesota (4 trials); Stanford, California (2 trials); Los Angeles, California (2 trials); Mobile, Alabama (1 trial); Chandler, Arizona (1 trial) and 7 other cities.
Featured Uterine Fibroids Studies
Highlighted recruiting studies for uterine fibroids, selected by enrollment size and research scope.
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with heavy menstrual bleeding associated with uterine leiomyomas (fibroids) or with moderate-to-severe pain associated with endometriosis.
Safety and Durability of Sirolimus for Treatment of LAM
The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR inhibitors (sirolimus or everolimus) as part of their clinical care. Adult female TSC patients may also enroll, with or without lung cysts.
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
Frequently Asked Questions About Uterine Fibroids Clinical Trials
Are there uterine fibroids clinical trials near me?
Yes, there are 9 uterine fibroids clinical trials currently recruiting across 29+ cities in the United States, including Rochester, Minnesota; Stanford, California; Los Angeles, California. Browse the studies above to find one at a location convenient for you.
How do I join a uterine fibroids clinical trial?
To join a uterine fibroids clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are uterine fibroids clinical trials free?
Yes, participation in uterine fibroids clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of uterine fibroids treatments are being studied?
Current uterine fibroids clinical trials are testing a range of approaches across NA (2 studies), PHASE1 (2 studies), PHASE2 (2 studies), PHASE3 (1 study), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 9 research organizations.
Is it safe to participate in uterine fibroids clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov